# An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

> **NCT01735214** · — · COMPLETED · sponsor: **Allergan** · enrollment: 358 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **DRUG:** Prostaglandin Analogue -Containing IOP-Lowering Therapy

## Key facts

- **NCT ID:** NCT01735214
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-07
- **Primary completion:** 2014-04-10
- **Final completion:** 2014-04-10
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2019-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735214, "An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01735214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*